Background. The goal of the trial was to determine the efficacy of a multicomponent acellular
pertussis vaccine against Bordetella illnesses in comparison with a whole-cell product and …

A new generation of recombinant acellular pertussis vaccine containing genetically
inactivated pertussis toxin (PTgen) was licensed as a monovalent pertussis vaccine (aP gen; …

The review is devoted to the analysis of pertussis incidence of children in the age group of 5–
7, as well as strategies of DTP immunization with the help of the drugs in foreign countries …

Background: Currently recommended whole cell pertussis (wP) vaccination schedule for
children includes a 3-dose primary schedule, and at least one booster dose. When …

BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …

Although tetanus and diphtheria have become rare in developed countries, pertussis is still
endemic in some developed countries. These are vaccine-preventable diseases and …

Reduced-antigen-content pertussis vaccines designed initially for booster vaccination of
adolescents and adults can also be used to vaccinate pre-school age children. Combination …

抄録 Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine is
generally used for booster vaccination of infants in Europe and the United States to avoid …

We compared the reactions and immunogenicity of DT acellular pertussis (DTaP) vaccines
containing pertussis toxoid (PT) and filamentous haemagglutinin (FHA)(2-component DTaP) …

Objective: To evaluate the safety and the immunogenicity of a booster dose of recombinant
acellular pertussis vaccine combined with diphtheria and tetanus toxoids (DTaP, Biocine …